Inventor · disambiguated record
Joshua A. Kaplan
Also filed as: KAPLAN JOSHUA · KAPLAN JOSHUA A · KAPLAN JOSHUA AARON
38 granted patents·11 pending applications·205 citations·filing 2004–2025
97Inventor score
Top patents by PatentIndex Score
49 records- 0196US11584738B2LPA receptor antagonists and uses thereofGILEAD SCIENCES INC·Filed 2021·Granted Feb 21, 2023·11 cites·47 claims
- 0293US10328053B2Substituted pyrrolizine compounds and uses thereofGILEAD SCIENCES INC·Filed 2017·Granted Jun 25, 2019·4 cites·7 claims
- 0392US8039469B2Triazine compounds as PI3 kinase and mTOR inhibitorsWYETH LLC·Filed 2009·Granted Oct 18, 2011·15 cites·17 claims
- 0491US10022381B2Triazine compounds as PI3 kinase and mTOR inhibitorsWYETH LLC·Filed 2015·Granted Jul 17, 2018·5 cites·6 claims
- 0591US9765060B2Phosphatidylinositol 3-kinase inhibitorsGILEAD SCIENCES INC·Filed 2015·Granted Sep 19, 2017·13 cites·2 claims
- 0691US8748421B2Triazine compounds as P13 kinase and MTOR inhibitorsWYETH LLC·Filed 2013·Granted Jun 10, 2014·11 cites·9 claims
- 0790US12049439B2Sulfinylaminobenzamide and sulfonylaminobenzamide derivativesORSOBIO INC·Filed 2021·Granted Jul 30, 2024·2 cites·50 claims
- 0889US8859542B2Triazine compounds as PI3 kinase and mTOR inhibitorsWYETH LLC·Filed 2014·Granted Oct 14, 2014·9 cites·12 claims
- 0989US8575159B2Triazine compounds as PI3 kinase and mTOR inhibitorsPFIZER·Filed 2012·Granted Nov 5, 2013·9 cites·21 claims
- 1089US8217036B2Triazine compounds as PI3 kinase and mTOR inhibitorsVENKATESAN ARANAPAKAM MUDUMBAI·Filed 2011·Granted Jul 10, 2012·12 cites·10 claims
- 1189US7713994B2Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo,1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihyro-3 (2H)-isoquinolones and methods of use thereofWYETH LLC·Filed 2007·Granted May 11, 2010·27 cites·18 claims
- 1289US7626023B2Compounds for treating tumorsWYETH CORP·Filed 2008·Granted Dec 1, 2009·12 cites·13 claims
- 1388US10040781B2Tank-binding kinase inhibitor compoundsGILEAD SCIENCES INC·Filed 2015·Granted Aug 7, 2018·3 cites·48 claims
- 1488US9029384B2Phosphatidylinositol 3-kinase inhibitorsGILEAD CALISTOGA LLC·Filed 2013·Granted May 12, 2015·10 cites·16 claims
- 1587US10874640B2Substituted pyrrolizine compounds and uses thereofGILEAD SCIENCES INC·Filed 2019·Granted Dec 29, 2020·2 cites·5 claims
- 1687US9221795B2Phosphatidylinositol 3-kinase inhibitorsGILEAD SCIENCES INC·Filed 2014·Granted Dec 29, 2015·9 cites·59 claims
- 1785US9174963B2Triazine compounds as PI3 kinase and MTOR inhibitorsWYETH LLC·Filed 2014·Granted Nov 3, 2015·5 cites·2 claims
- 1885US7390910B2Compounds for treating tumorsWYETH CORP·Filed 2004·Granted Jun 24, 2008·14 cites·45 claims
- 1984US11136290B2Sulfinylaminobenzamide and sulfonylaminobenzamide derivativesTHE LIVER COMPANY INC·Filed 2019·Granted Oct 5, 2021·5 cites·43 claims
- 2084US8445486B2Triazine compounds as PI3 kinase and mTOR inhibitorsVENKATESAN ARANAPAKAM MUDUMBAI·Filed 2012·Granted May 21, 2013·5 cites·10 claims
- 2183US8129371B2Thienopyrimidine and pyrazolopyrimidine compounds and their use as mTOR kinase and PI3 kinase inhibitorsZASK ARIE·Filed 2008·Granted Mar 6, 2012·11 cites·46 claims
- 2281US10072001B2Tank-binding kinase inhibitor compoundsGILEAD SCIENCES INC·Filed 2015·Granted Sep 11, 2018·3 cites·30 claims
- 2380US12161625B2Substituted pyrrolizine compounds and uses thereofGILEAD SCIENCES INC·Filed 2022·Granted Dec 10, 2024·0 cites·23 claims
- 2477US11225473B2FXR (NR1H4) modulating compoundsGILEAD SCIENCES INC·Filed 2020·Granted Jan 18, 2022·1 cites·19 claims
- 2577US2025026744A1Fxr (nr1h4) modulating compoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 2676US10221197B2Phosphatidylinositol 3-kinase inhibitorsGILEAD SCIENCES INC·Filed 2015·Granted Mar 5, 2019·2 cites·13 claims
- 2775US10092563B2Phosphatidylinositol 3-kinase inhibitorsGILEAD SCIENCES INC·Filed 2015·Granted Oct 9, 2018·2 cites·11 claims
- 2872US7666901B2Analogs of 17-hydroxywortmannin as PI3K inhibitorsWYETH CORP·Filed 2005·Granted Feb 23, 2010·2 cites·15 claims
- 2972US2025304554A1Lpa receptor antagonists and uses thereofGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 3070US2021251957A1Substituted pyrrolizine compounds and uses thereofGILEAD SCIENCES INC·Filed 2020·Application pending·0 cites
- 3168US11939318B2LPA receptor antagonists and uses thereofGILEAD SCIENCES INC·Filed 2022·Granted Mar 26, 2024·0 cites·20 claims
- 3267US10308639B2Phosphatidylinositol 3-kinase inhibitorsGILEAD SCIENCES INC·Filed 2015·Granted Jun 4, 2019·1 cites·20 claims
- 3364US12410160B2KHK inhibitorsGILEAD SCIENCES INC·Filed 2022·Granted Sep 9, 2025·0 cites·38 claims
- 3463US2022204491A1Fxr (nr1h4) modulating compoundsGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 3559US10253019B2Tank-binding kinase inhibitor compoundsGILEAD SCIENCES INC·Filed 2018·Granted Apr 9, 2019·0 cites·13 claims
- 3656US11980609B2LPA receptor antagonists and uses thereofGILEAD SCIENCES INC·Filed 2022·Granted May 14, 2024·0 cites·14 claims
- 3755US2009192176A11H-PYRAZOLO[3,4-D]PYRIMIDINE, PURINE, 7H-PURIN-8(9H)-ONE, 3H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE, AND THIENO[3,2-D]PYRIMIDINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESESWYETH CORP·Filed 2009·Application pending·0 cites
- 3852US10259811B2Tank-binding kinase inhibitor compoundsGILEAD SCIENCES INC·Filed 2018·Granted Apr 16, 2019·0 cites·10 claims
- 3948US2008234262A1Pyrazolopyrimidine analogs and their use as mtor kinase and pi3 kinase inhibitorsWYETH CORP·Filed 2008·Application pending·0 cites
- 4048US2018065953A1Phosphatidylinositol 3-kinase inhibitorsGILEAD SCIENCES INC·Filed 2017·Application pending·0 cites
- 4147US2013012504A1Bi-functional quinoline analogsGILEAD SCIENCES INC·Filed 2012·Application pending·0 cites
- 4247US2008233127A1Imidazolopyrimidine analogs and their use as pi3 kinase and mtor inhibitorsWYETH CORP·Filed 2008·Application pending·0 cites
- 4346US8367829B2Bi-functional pyrazolopyridine compoundsGILEAD SCIENCES INC·Filed 2011·Granted Feb 5, 2013·0 cites·18 claims
- 4443US8450490B2Bi-functional pyrazolopyridine compoundsBAKER WILLIAM R·Filed 2012·Granted May 28, 2013·0 cites·4 claims
- 4543US2016039793A1Phosphatidylinositol 3-kinase inhibitorsGILEAD SCIENCES INC·Filed 2015·Application pending·0 cites
- 4641US2016016915A1Phosphatidylinositol 3-kinase inhibitorsGILEAD CALISTOGA LLC·Filed 2015·Application pending·0 cites
- 4739US8394829B2Bi-functional quinoline analogsBAKER WILLIAM R·Filed 2011·Granted Mar 12, 2013·0 cites·26 claims
- 4838US10316049B2Tank-binding kinase inhibitor compoundsGILEAD SCIENCES INC·Filed 2016·Granted Jun 11, 2019·0 cites·59 claims
- 4929US8835429B2Pyrimidine compounds, their use as mTOR kinase and Pl3 kinase inhibitors, and their synthesesCURRAN KEVIN JOSEPH·Filed 2010·Granted Sep 16, 2014·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Joshua A. Kaplan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →